{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:26:20Z","timestamp":1774862780471,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jhep.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:57:52Z","timestamp":1744199872000},"page":"e212-e213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of enteric-coated mycophenolate sodium as a therapeutic option for autoimmune hepatitis"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5586-4385","authenticated-orcid":false,"given":"Manuel","family":"Garrido Montes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3121-1728","authenticated-orcid":false,"given":"Luis","family":"Luque Caraballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8158-273X","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Sousa Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jhep.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jhep.2024.12.041","article-title":"Update in clinical science: autoimmune hepatitis","volume":"82","author":"Heneghan","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.002_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.medcli.2022.04.004","article-title":"Autoimmune hepatitis: challenges and novelties","volume":"159","author":"Olivas","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jhep.2025.04.002_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jhep.2022.09.026","article-title":"2022 International autoimmune hepatitis group non-response criteria in autoimmune hepatitis: quick vs. slow responders","volume":"78","author":"Engel","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ckj\/sfu096","article-title":"Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease","volume":"7","author":"Jones","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jhep.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/rheumatology\/keq238","article-title":"Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil","volume":"49","author":"Schaier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jhep.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1345\/aph.1D063","article-title":"Enteric-coated mycophenolate sodium","volume":"37","author":"Gabardi","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhep.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0012.2004.00318.x","article-title":"Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil","volume":"19","author":"Arns","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance","volume":"14","author":"H\u00fcbener","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:41:23Z","timestamp":1774860083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0168827825002284"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.002","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of enteric-coated mycophenolate sodium as a therapeutic option for autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.12.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}